Society guideline links: Acne vulgaris

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Canada

●Don't use oral antibiotics for acne vulgaris for more than 3 months without assessing efficacy (updated 2020)

●Canadian clinical practice guideline for the management of acne (2016)

United States

●Choosing Wisely: Don't routinely use microbiologic testing in the evaluation and management of acne (updated 2021)

●American Academy of Dermatology (AAD): Guidelines of care for the management of acne vulgaris (2016)

●American Acne and Rosacea Society (AARS): Evidence-based recommendations for the diagnosis and treatment of pediatric acne (2013)

Europe

●European Dermatology Forum (EDF): European evidence-based (S3) guideline for the treatment of acne, update (2016)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on acne vulgaris – Management (2021)

India

●Indian Acne Alliance (IAA): Consensus document – Acne in India: Guidelines for management (2009)

Australia–New Zealand

●Australasian College of Dermatologists (ACD): Position statement – Isotretinoin for treatment of acne (2022)

●Choosing Wisely Australia: Monotherapy for acne with either topical or systemic antibiotics should be avoided (reviewed 2016)